Recent Work Arbor Pharmaceuticals Ireland Limited
Share This

Arbor Pharmaceuticals Ireland Limited

Thursday, 19 September 2013

ByrneWallace advised Arbor Pharmaceuticals Ireland Limited on its licensing, development and commercialization agreement with the Japanese pharmaceutical company, Takeda Pharmaceuticals for its hypertension products, EDARBI and EDARBYCHLOR.